Better Care. Smarter Solutions.
Better Care. Smarter Solutions.
At Heartland Biologics, we provide healthcare providers with access to a focused portfolio of advanced wound care solutions selected for their clinical relevance and practical application. These solutions are designed to support the wound healing environment across a variety of wound types, offering providers flexible options that can be integrated into existing care protocols.
Our approach emphasizes consistency, ease of use, and alignment with real-world clinical workflows. By offering a combination of advanced materials and technologies, we help teams address complex wounds while maintaining a straightforward and adaptable treatment approach. Each solution is supported by product-specific training and reimbursement guidance to help your team implement them with confidence.
Below, you’ll find access to product information and supporting materials, including clinical details and usage guidance. If you have questions or would like help determining which solutions may be appropriate for your patients and practice, our team is available to provide additional insight.
PHOENIX Wound Matrix® is an engineered synthetic matrix comprised of known polymers, Polyglycolic Acid (PGA) and Poly-lactide-co-caprolactone (PLCL), each with a long & safe history in numerous medical applications. The polymers are electrospun into nanofibers designed to serve as a scaffold that mimics the body’s native Extracellular Matrix in an efficient, consistent and scalable manner. The polymers fully resorb over 7-14 days releasing glycolic acid, caproic acid and lactic acid, each of which are recognized contributors that transform pH levels, modulate inflammation and fuel cellular activity. PHOENIX Wound Matrix® is indicated as a 510k medical device for use in the management of all full and partial thickness wounds.
OMEZA® OCM is a fish-derived acellular matrix made from purified marine peptides and formulated as a topical product to support the wound healing environment. Processed to preserve key structural and bioactive components while removing cellular material, it is designed to provide a protective, supportive covering for the wound bed and can be incorporated into standard wound care protocols. OMEZA® OCM is indicated for the management of acute and chronic wounds, including diabetic ulcers, venous ulcers, pressure ulcers, surgical wounds, and traumatic wounds. It is supplied in a tube for controlled, targeted application and is available in multiple sizes to accommodate a range of wound types and clinical needs.
BioLab Membrane Wrap™ is a readily available amnion-amnion human tissue allograft derived from the amniotic membrane that serves as a barrier and provides protective covering for the wound. It is minimally manipulated, preserving the properties exhibited in its natural state*, while remaining compliant with FDA Regulations. This product helps aid chronic wounds with their promoting healing factors while also providing antimicrobial properties, helping to aid chronic wounds into healing. All BioLab Holdings Membrane Wrap™ allograft tissue products have been tested for potentially infectious diseases and terminally sterilized to ensure the safety of each membrane.
We’d love to hear from you. Whether you have questions about our program, need more information about our services, or are interested in exploring partnership opportunities, feel free to reach out. A member of our team will respond promptly to assist you.
Thank you for contacting us! Your inquiry has been received, and a member of our team will be in touch with you shortly. We appreciate your interest in our wound care services and look forward to supporting your facility and patients.
While our website is being built, please contact us below with any questions. We are quick to respond.
Your message was sent successfully.
We will see it soon and respond accordingly.
